Value-Based Care for Addiction Treatment
Caron's Model for SUD Treatment Works
To advance our mission of Recovery For Life, we developed insurance partnerships to increase the access to high quality care to treat more people. As evidenced in a 2016 Independence Blue Cross (IBC) pilot study of value-based care, which was presented at the 2021 RxSummit, Caron's model for substance use disorder (SUD) treatment works.
Caron partnered with IBC to pilot a reimbursement model that allowed us to provide the patient-centric care we knew worked. The high rate (94.4%) of 90-day post-treatment recovery shows that Caron's approach on quality, interdisciplinary treatment protocols with a median inpatient stay of 25 days, combined with a long-term disease management plan, is successful. A value-based or outcomes-driven reimbursement model supports the treatment of SUD as a chronic, treatable brain disease because it prioritizes the use of evidence-based practices, medically appropriate modalities and appropriate length of stay.
When you treat addiction as the chronic disease it is, by focusing on the individual needs of the patient mentally, physically and spiritually as well as the family and having the length of time you need to truly treat the individual – you get better outcomes for patients."
Q&A with Brad Sorte and Doug Tieman
Perspectives on the CEO transition, accomplishments, challenges and opportunities for Caron and the addiction treatment community
Pioneering Research for Addiction Medicine
Caron's Fran & Doug Tieman Center for Research will focus on brain chemistry and medical research to leverage scientific advancements and increase the probability of Recovery For Life.
Caron Treatment Centers Cuts Unusual Contract with…
By Addiction Recovery eBulletin
Caron Treatment Centers Announces First-Of-Its-Kind Medical…
By Caron Staff
Caron Leverages Value-Based Care to Improve Access, Move…
By Behavioral Health Business
Bradley F. Sorte Officially Becomes the Next President and…
By Caron Staff
Caron Treatment Centers cuts readmissions under unusual…
By The Philadelphia Inquirer